Default company panoramic image
Logo

Regenerative Medical Solutions

RMS utilizes patented technology to grow iPSC-derived pancreatic cells for dual use as research tools and direct cell therapeutic targeting diabetes

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Madison, WI, USA
  • Currency USD
  • Founded January 2012
  • Employees 10
  • Incorporation Type C-corp
  • Website regenmedsolutions.com

Company Summary

Regenerative Medical Solutions was established to commercialize patented technology, exclusively licensed from the University of Wisconsin, to grow iPSC-derived pancreatic cells for dual use as research tools and direct cell therapeutic targeting diabetes. RMS is utilizing and building upon patented technology under world renowned stem cell scientist and pancreatic transplant surgeon, Dr. Jon Odorico, and RMS’ dedicated team of scientists.

Team

  • Default avatar
    Anthony D Kolton
    Executive Chairman, Co-Founder

    Mr. Kolton has had extensive experience and a successful track record in both start-up and technology companies. He founded LIM in 1988 with $4,000 in capital and, under his direction as President, turned the company into a business with revenues over $20 million per year. In December 2009, LIM was sold to Morningstar for over $50 million. Mr. Kolton earned a BS in Accounting along with his CPA certificate. He has MA in Taxation and a JD.

  • Default avatar
    Jon Odorico, M.D., F.A.C.S
    Chief Scientific Officer, Co-Founder

    Dr. Jon Odorico currently serves as the Chief Scientific Officer of RMS and is responsible for the overall scientific direction of the company. Dr. Odorico is also an Associate Professor, Department of Surgery, Division of Organ Transplantation at the University of Wisconsin-Madison in Madison, WI. Dr. Odorico is certified by the American Board of Surgery and specializes in pancreas transplants, islet cell transplants and multi-organ transplants.

  • Default avatar
    Tom Joyce
    Vice President

    Tom Joyce is VP of Corporate Development and Administration of RMS. In this role he manages day-to-day operations of finance, marketing and logistics for RMS. He previously was a key market researcher with Logical Information Machines specializing in developing data, conducting research and streamlining financial operations. Mr. Joyce graduated Summa Cum Laude with a degree in Finance and Banking from the University of Missouri-Columbia.

  • Default avatar
    Richard Ganz
    President and CEO

    Rich Ganz is President and CEO of RMS. Formerly, Mr. Ganz was Chief Operating Officer of Piramal Critical Care, a global pharmaceutical company headquartered in Bethlehem, PA, President and Chief Executive Officer at Omnisonics Medical Technologies, President of the North American Renal Division for Baxter International, Inc., and a Divisional VP and General Manager of Vascular Products at Abbott Laboratories.